Philips: UBS raises target price, sees buy opportunity
(CercleFinance.com) - UBS has its target price for the Philips share to 48 euros from 42.
50 euros, after the Dutch health technology company reported its fourth-quarter results.
"We see Philips' disappointing fourth-quarter as a buying opportunity and continue to believe our investment thesis," the broker wrote in a note.
UBS said that it is maintaining its "conviction" for 2020, centred on growth in diagnosis and treatment (D&T), ongoing personal health (PH) recovery, and scope for margin expansion.
UBS reiterated its "buy" rating on the stock, which is currently up 0.3% at 43,3 euros on Euronext Amsterdam.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
50 euros, after the Dutch health technology company reported its fourth-quarter results.
"We see Philips' disappointing fourth-quarter as a buying opportunity and continue to believe our investment thesis," the broker wrote in a note.
UBS said that it is maintaining its "conviction" for 2020, centred on growth in diagnosis and treatment (D&T), ongoing personal health (PH) recovery, and scope for margin expansion.
UBS reiterated its "buy" rating on the stock, which is currently up 0.3% at 43,3 euros on Euronext Amsterdam.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.